Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

201 - 210 of 4730 results found

Targeting SIRT1 by Scopoletin to Inhibit XBB.1.5 COVID-19 Life Cycle

Date
Tuesday, March 05, 2024 - 4:00 AM
Description
Natural products have historically driven pharmaceutical discovery, but their reliance has diminished with synthetic drugs. Approximately 35% of medicines originate from natural products. Scopoletin, a natural coumarin compound found in herbs

The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

Date
Tuesday, March 05, 2024 - 4:00 AM
Description
Studies investigating the immunogenicity of additional COVID-19 vaccine doses in immunosuppressed patients with inflammatory rheumatic diseases (IRD) are still limited. The objective was to explore the antibody response including response to omicron

The shifting impact and response to COVID-19 in Florida

Date
Tuesday, March 05, 2024 - 4:00 AM
Description
The first cases of COVID-19 in Florida were diagnosed on March 1, 2020. Three years later, more than 7.3 million people have had COVID-19 in Florida, and more than 93,000 individuals have died from this illness. When considering the impact of COVID

The relationship between autophagy and respiratory viruses

Date
Monday, March 04, 2024 - 4:00 AM
Description
Respiratory viruses have caused severe global health problems and posed essential challenges to the medical community. In recent years, the role of autophagy as a critical process in cells in viral respiratory diseases has been noticed. One of the